In-vitro activity of Sch 29482, MK 0787, ceftriaxone and seven other antimicrobials against 840 separate clinical isolates.
D000332:Aerobiosis; D000693:Anaerobiosis; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000382:microbiology; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000494:pharmacology; D002443:Ceftriaxone; D002513:Cephamycins / Q000494:pharmacology; D006801:Humans; D015378:Imipenem; D007769:Lactams / Q000494:pharmacology; D008712:Methicillin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009070:Moxalactam; D010403:Penicillin Resistance
D000900:Anti-Bacterial Agents; D002513:Cephamycins; D007769:Lactams; D015378:Imipenem; D002443:Ceftriaxone; C033922:Sch 29482; D002439:Cefotaxime; D008712:Methicillin; D009070:Moxalactam